Jump to first page Relational Data. Jump to first page Inductive Logic Programming (ILP) n Can use ILP to find a set of rules capturing a property that.

Slides:



Advertisements
Similar presentations
Christopher Reynolds Supervisor: Prof. Michael Sternberg Bioinformatics Department Division of Molecular Biosciences Imperial College London.
Advertisements

1 Sequential Screening S. Stanley Young NISS HTS Workshop October 25, 2002.
Protein Structure and Function Review: Fibrous vs. Globular Proteins.
3D Molecular Structures C371 Fall Morgan Algorithm (Leach & Gillet, p. 8)
Suggested readings on regulation/dna bp Watson pp , Voet pp Problems 2, 4 Here’s a quiz on the lac operon:quiz
1 PharmID: A New Algorithm for Pharmacophore Identification Stan Young Jun Feng and Ashish Sanil NISSMPDM 3 June 2005.
University of Wisconsin ISMB 2002 Department of Biostatistics Department of Computer Science Mining Three-dimensional Chemical Structure Data Sean McIlwain.
Solving the Multiple-Instance Problem with Axis-Parallel Rectangles By Thomas G. Dietterich, Richard H. Lathrop, and Tomás Lozano-Pérez Appeared in Artificial.
FLEX* - REVIEW.
Structural biology and drug design: An overview Olivier Taboureau Assitant professor Chemoinformatics group-CBS-DTU
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
 Definition of metabolism  Definition of a substrate  Characteristics of metabolic pathways  Why we need metabolic pathways.
Pharmacophore and FTrees
Molecular Descriptors
Topological Summaries: Using Graphs for Chemical Searching and Mining Graphs are a flexible & unifying model Scalable similarity searches through novel.
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Biochemistry Sixth Edition Chapter 31 The Control of Gene Expression Part II: Eukaryotes (cis vs. trans) Copyright © 2007 by W. H. Freeman and Company.
The importance of a good representation Properties of a good representation: Reveals important features Hides irrelevant detail Exposes useful constraints.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Electricity Chapter 17 Section 1 (pages ).
CHAPTER 6 AN INTRODUCTION TO METABOLISM The Control of Metabolism 1.Metabolic control often depends on allosteric regulation 2.The localization of enzymes.
Previously in Cell Bio Signals are detected via binding interactions Binding interactions governed by protein folding Protein folding dictated by amino.
Molecular mechanics Classical physics, treats atoms as spheres Calculations are rapid, even for large molecules Useful for studying conformations Cannot.
Title: Lesson 4 B.2 Enzymes Learning Objectives: – Describe the structure and the function of an enzyme – Identify and explain the factors that affect.
Molecular Modeling in Drug Discovery: an Overview
HP-SEE In the search of the HDAC-1 inhibitors. The preliminary results of ligand based virtual screening Ilija N. Cvijetić, Ivan O. Juranić,
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Cell membranes are composed of two phospholipid layers.
Enzymes Chapter 8.
It’s in the genes Lesson 3.2.
SDS-Polyacrylamide Gel Electrophoresis Agarose vs. SDS-PAGE
Protein Structures There are 4 protein structures.
Volume 11, Issue 8, Pages (August 2003)
The Energy of Life Chapter 8.4.
Ligand binding sites Roman Laskowski.
Metabolic Pathways (c)
Properties of Water.
Factors Affecting ENZYME Activity
PHL 210 Pharmacology Second Lecture By Abdelkader Ashour, Ph.D. Phone:
Aim: Why are Enzymes necessary for our survival?
Enzymes Learning Outcome B11.
Part 2 INHIBITION ALLOSTERIC REGULATION FEEDBACK INHIBITION
Transcription Factors
Virtual Screening.
Enzymes.
N. Dietis, R. Guerrini, G. Calo, S. Salvadori, D. J. Rowbotham, D. G
DNA Notes.
Patterns of control of gene expression
Metabolism 8.1.
Enzymes Chapter 8 Section 8.2.
Enzymes pp
Enzymes Lecture #8.
List a Carbohydrate Monomer
Structure-based drug design: progress, results and challenges
Volume 11, Issue 8, Pages (August 2003)
Binding and Conformational Change
3.2 Review PBS.
CH. 6 Factors Affecting ENZYME Activity
Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies  C.P.R. Walker, D. Royston 
Mechanism of Triton binding to ShHTL7
Section C: The Control of Metabolism
Volume 14, Issue 5, Pages (May 2006)
Volume 12, Issue 11, Pages (November 2005)
3.2 Review PBS.
Section C: The Control of Metabolism
What is it and how does it work?
Enzyme Control of Metabolism
Section C: The Control of Metabolism
Volume 17, Issue 5, Pages (May 2009)
Presentation transcript:

Jump to first page Relational Data

Jump to first page Inductive Logic Programming (ILP) n Can use ILP to find a set of rules capturing a property that the positive graphs have in common that no negative graph has. n This property is a kind of disjunction of subgraphs, where we allow one node in the graph to possibly play the role of multiple nodes in the subgraph.

Jump to first page Rule

Jump to first page Pharmacophores n A drug is a (typically) small organic molecule capable of binding to a target protein. n Binding depends on shape and on locations of charged groups, hydrophobic groups, etc. n If exact structure of target site is known, drug design is relatively easy -- but this is rarely known.

Jump to first page Example of Binding

Jump to first page Typical Practice n Test many molecules (1,000,000) to find some that bind to target (ligands). n Infer (induce) shape of target site from 3D structural similarities. n Shared 3D substructure is called a pharmacophore. n Perfect example of a machine learning task with spatial target.

Jump to first page

Pharmacophore expressed in English A Molecule M is active against Pseudomonas Aeruginosa if it has a conformation B such that: M has a hydrophobic group C, M has a hydrogen acceptor D, the distance between C and D in conformation B is 11.7 Angstroms M has a positively-charged atom E, the distance between C and E in conformation B is 4 Angstroms the distance between D and E in conformation B is 9.4 Angstroms M has a positively-charged atom F, the distance between C and F in conformation B is 11.1 Angstroms the distance between D and F in conformation B is 12.6 Angstroms the distance between E and F in conformation B is 8.7 Angstroms Tolerance 1.5 Angstroms

Jump to first page Obvious Question 1 n Why don’t we just use one of the ligands (hits) as the drug? n Typically they don’t meet all the other requirements for drugs: u Non-toxic (other side effects) u Active enough (drink 2 gallons) u Metabolism (lasts long enough but not too long in the body) u Take by mouth? (gut-bloodstream)

Jump to first page Obvious Question 2 n Why doesn’t a chemist just look at the ligands and figure out what they have in common? n Each molecule has many different shapes (conformers), any one of which might be the active one. Multiple instance problem (Dietterich, Lathrop, Lozano-Perez) n May be many molecules.

Jump to first page The Logical Representation of a Pharmacophore

Jump to first page ACE Pharmacophore n Molecule A is an ACE inhibitor if: n molecule A contains a zinc-site B, n molecule A contains a hydrogen acceptor C, n the distance between B and C is / A, n molecule A contains a hydrogen acceptor D, n the distance between B and D is / A, n the distance between C and D is / A, n molecule A contains a hydrogen acceptor E, n the distance between B and E is / A, n the distance between C and E is / A, n the distance between D and E is / A.

Jump to first page Molecule 1

Jump to first page

Protein Function Gene Sequence Structural Motifs Chromosomal Location Gene/Protein LevelInteractions Gene Expression Protein Interactions FUNCTION